Shapira, M Y <br/><br/>
A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation.  [electronic resource] 

 -  Bone marrow transplantation  Sep 2003 
 - 557-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1704190  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Busulfan--administration & dosage<br/>Cyclosporine--therapeutic use<br/>Female<br/>Graft Survival<br/>Graft vs Host Disease--drug therapy<br/>Hematopoietic Stem Cell Mobilization<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Male<br/>Middle Aged<br/>Neoplasms--mortality<br/>Patient Selection<br/>Pilot Projects<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Vidarabine--administration & dosage